SynthesisFrontiers in public health2026
The effects of visual art therapy in older adults with mild cognitive impairment: a systematic review and meta-analysis.
Synthesis in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lessons learned from virtual arts-based resilience workshops for military healthcare providers: a community case study.Frontiers in psychology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically evaluate the effectiveness of visual art therapy (VAT) in older adults with mild cognitive impairment (MCI). Methods: A systematic search of multiple bibliographic databases and gray literature sources was conducted from inception to January 25, 2026, and RCTs comparing VAT with control conditions were included. Two reviewers independently screened studies, extracted data, and assessed risk of bias. Continuous outcomes were pooled using a random-effects model and summarized as SMDs or MDs. Heterogeneity was assessed using Cochran's Results: Nine RCTs ( Conclusion: Current RCT evidence suggests that VAT improves global cognition in older adults with MCI and may improve memory, depressive symptoms, and activities of daily living, whereas no clear benefit was found for language function. These findings require confirmation in larger, methodologically rigorous trials with more standardized outcome measurement. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251167927, CRD420251167927.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.